EMILIMOGENE SIGULACTIBAC TRANSGENE PLASMID
UNII BJH8KD4UJX

Substance Identification & Data

This profile provides standardized clinical and technical data for Emilimogene Sigulactibac Transgene Plasmid, uniquely identified by the FDA Unique Ingredient Identifier (UNII) BJH8KD4UJX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BJH8KD4UJX
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EMILIMOGENE SIGULACTIBAC TRANSGENE PLASMID
Official standardized name for this substance within the FDA UNII nomenclature system.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emilimogene Sigulactibac Transgene Plasmid. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

EMILIMOGENE SIGULACTIBAC TRANSGENE PLASMID
EMILIMOGENE SIGULACTIBAC TRANSGENE PLASMID (PLASMID EXPRESSING A CODON-OPTIMISED HUMAN C-X-C MOTIF CHEMOKINE LIGAND 12 ISOFORM ALPHA (CXCL12-1.ALPHA.; ALSO KNOWN AS STROMAL CELL-DERIVED FACTOR 1 ISOFORM ALPHA) WITH THE NATIVE SECRETION SIGNAL REPLACED WITH THE SECRETION SIGNAL OF THE L. REUTERI COLLAGEN-BINDING PROTEIN, UNDER CONTROL OF THE INDUCIBLE PROMOTER PORFX (PART OF A PEPTIDE-BASED QUORUM-SENSING SYSTEM))

External Clinical & Regulatory Resources

NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record